Acadia Pharmaceuticals (ACAD) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.05% |
| Dec 31, 2025 | 0.42% |
| Sep 30, 2025 | -8.09% |
| Jun 30, 2025 | 26.01% |
| Mar 31, 2025 | 8.90% |
| Dec 31, 2024 | -60.06% |
| Sep 30, 2024 | 66.81% |
| Jun 30, 2024 | 6.34% |
| Mar 31, 2024 | -18.16% |
| Dec 31, 2023 | -2.78% |
| Sep 30, 2023 | 22.34% |
| Jun 30, 2023 | 3.05% |
| Mar 31, 2023 | 2.02% |
| Dec 31, 2022 | -21.29% |
| Sep 30, 2022 | -10.73% |
| Jun 30, 2022 | 37.08% |
| Mar 31, 2022 | 16.17% |
| Dec 31, 2021 | -17.15% |
| Sep 30, 2021 | -29.35% |
| Jun 30, 2021 | 66.91% |
| Mar 31, 2021 | -37.80% |
| Dec 31, 2020 | -0.83% |
| Sep 30, 2020 | 9.56% |
| Jun 30, 2020 | -12.71% |
| Mar 31, 2020 | 13.08% |
| Dec 31, 2019 | -10.26% |
| Sep 30, 2019 | 7.84% |
| Jun 30, 2019 | 2.71% |
| Mar 31, 2019 | -2.54% |
| Dec 31, 2018 | 1.15% |
| Sep 30, 2018 | -1.86% |
| Jun 30, 2018 | 0.54% |
| Mar 31, 2018 | -7.16% |
| Dec 31, 2017 | 11.78% |
| Sep 30, 2017 | 7.97% |
| Jun 30, 2017 | 17.17% |
| Mar 31, 2017 | 0.99% |
| Dec 31, 2016 | 10.06% |
| Sep 30, 2016 | 0.91% |
| Jun 30, 2016 | 16.13% |
| Mar 31, 2016 | 34.30% |
| Dec 31, 2015 | -3.92% |
| Sep 30, 2015 | 23.55% |
| Jun 30, 2015 | -48.38% |
| Mar 31, 2015 | 212.77% |
| Dec 31, 2014 | 242.05% |
| Sep 30, 2014 | -68.42% |
| Jun 30, 2014 | 35.99% |
| Mar 31, 2014 | 45.45% |
| Dec 31, 2013 | 81.02% |
| Sep 30, 2013 | 9.18% |
| Jun 30, 2013 | 89.00% |
| Mar 31, 2013 | 5.63% |
| Dec 31, 2012 | 12.91% |
| Sep 30, 2012 | 2.09% |
| Jun 30, 2012 | 15.74% |
| Mar 31, 2012 | 1.23% |
| Dec 31, 2011 | 1.75% |
| Sep 30, 2011 | -2.91% |
| Jun 30, 2011 | 10.13% |
| Mar 31, 2011 | 11.61% |
| Dec 31, 2010 | 152.63% |